Totally with you fyffee. I did a similar analysis and also got $1000 a share. Lots may laugh, but that's what the numbers show even without being aggressive.Amazing thing is this is based upon just a fraction of the diseases NNZ-2591 could treat.If Neuren succeeds strongly in all 4 Ph 2 trials this will strengthen the argument for valuing NNZ-2591 on this much wider potential. If this value can be realised I suspect we're talking about a future benefit to whoever brings this potential to market of the order of $500b.We're clearly nowhere near that point yet , but that's the target Neuren is legitimately aiming for, and any near term T/O will hopefully be priced based upon this.
Share Price, page-8701
-
- There are more pages in this discussion • 3,889 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.13 |
Change
0.020(0.15%) |
Mkt cap ! $1.678B | |||
| Open | High | Low | Value | Volume |
| $13.20 | $13.44 | $13.07 | $5.021M | 378.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 11501 | $13.12 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.18 | 1539 | 1 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| NEU (ASX) Chart |